Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, August 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

So far, Dimensions has found 29 publications that cite this research output.

Preprint in Research Square (June 2023)

Article in International Journal of Molecular Sciences (May 2023)

Preprint in bioRxiv (April 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.